Company / Free Cash Flow per Share
Caribou Biosciences, Inc. Free Cash Flow per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$1.22
FY2025
5-year range
-$3.39 / -$0.57
FY2021-FY2025
Trend
-2.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow per Share has fluctuated over the past 5 years, ranging from $-3.39 in FY2021 to $-0.57 in FY2022.
Based on SEC 10-K filings.
-1.22 in FY2025.
Improved from $-1.60 to $-1.22 over the past 2 years.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, free cash flow per share decreased 2.5% year-over-year.
- Peak free cash flow per share was recorded in FY2022.
- Lowest free cash flow per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.99 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.22 | -2.5% |
| FY2024 | -$1.19 | +25.7% |
| FY2023 | -$1.60 | -177.7% |
| FY2022 | -$0.57 | +83.0% |
| FY2021 | -$3.39 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026